Acute exacerbations of asthma: Epidemiology, biology and the exacerbation-prone phenotype

Clinical and Experimental Allergy

Volumn 39, Issue 2, 2009, Pages 193-202

  Dougherty, R H ^a,b   Fahy, J V ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA INTERFERON; CORTICOSTEROID; EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HOUSE DUST ALLERGEN; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; NONSTEROID ANTIINFLAMMATORY AGENT; OMALIZUMAB; PLACEBO; POLLEN ANTIGEN; RANTES;

ASTHMA; CIGARETTE SMOKING; CLINICAL FEATURE; COMORBIDITY; DANDER; DEPRESSION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; EOSINOPHIL; EPITHELIUM CELL; EXERCISE; GASTROESOPHAGEAL REFLUX; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LUNG FUNCTION; LYMPHOCYTE; MORBIDITY; MORTALITY; NEUTROPHIL; OBESITY; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; RHINOSINUSITIS; RHINOVIRUS; STRESS; SYSTEMATIC REVIEW;

ALLERGENS; ASTHMA; COMORBIDITY; HUMANS; LUNG; MODELS, BIOLOGICAL; PATIENT COMPLIANCE; PSYCHOLOGY; VIRUS DISEASES;

EID: 58849162826     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2008.03157.x     Document Type: Review

References (102)

1. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 2001 164 (Part 1) : 1392 7.
2. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004 59 : 469 78.
3. CDC National Center for Health Statistics. Asthma prevalence, health care use and mortality: United States, 2003-05 [cited]; available from
4. Rodrigo GJ, Rodrigo C, Hall JB. Acute asthma in adults: a review. Chest 2004 125 : 1081 102.
5. Krishnan V, Diette GB, Rand CS et al. Mortality in patients hospitalized for asthma exacerbations in the United States. Am J Respir Crit Care Med 2006 174 : 633 8.
6. Busse WW. Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007 120 (Suppl.) : S94 138.
7. American Lung Association. Trends in asthma morbidity and mortality [cited]; available from
8. Centers for Disease Control. National surveillance for asthma - United States, 1980-2004. 2007 [updated 2007; cited]; available from
9. Caracta CF. Gender differences in pulmonary disease. Mt Sinai J Med 2003 70 : 215 24.
10. Redline S, Gold D. Challenges in interpreting gender differences in asthma. Am J Respir Crit Care Med 1994 150 (Part 1) : 1219 21.
11. Bjornson CL, Mitchell I. Gender differences in asthma in childhood and adolescence. J Gend Specif Med 2000 3 : 57 61.
12. Martinez-Moragon E, Plaza V, Serrano J et al. Near-fatal asthma related to menstruation. J Allergy Clin Immunol 2004 113 : 242 4.
13. Barr RG, Wentowski CC, Grodstein F et al. Prospective study of postmenopausal hormone use and newly diagnosed asthma and chronic obstructive pulmonary disease. Arch Intern Med 2004 164 : 379 86.
14. Melgert BN, Postma DS, Kuipers I et al. Female mice are more susceptible to the development of allergic airway inflammation than male mice. Clin Exp Allergy 2005 35 : 1496 503.
15. Erickson SE, Iribarren C, Tolstykh IV, Blanc PD, Eisner MD. Effect of race on asthma management and outcomes in a large, integrated managed care organization. Arch Intern Med 2007 167 : 1846 52.
16. Krishnan JA, Diette GB, Skinner EA, Clark BD, Steinwachs D, Wu AW. Race and sex differences in consistency of care with national asthma guidelines in managed care organizations. Arch Intern Med 2001 161 : 1660 8.
17. Haas JS, Cleary PD, Guadagnoli E, Fanta C, Epstein AM. The impact of socioeconomic status on the intensity of ambulatory treatment and health outcomes after hospital discharge for adults with asthma. J Gen Intern Med 1994 9 : 121 6.
18. Forester JP, Ong BA, Fallot A. Can equal access to care eliminate racial disparities in pediatric asthma outcomes? J Asthma 2008 45 : 211 4.
19. Persky V, Turyk M, Piorkowski J et al. Inner-city asthma: the role of the community. Chest 2007 132 (Suppl.) : 831S 9S.
20. Choudhry S, Taub M, Mei R et al. Genome-wide screen for asthma in Puerto Ricans: evidence for association with 5q23 region. Hum Genet 2008 123 : 455 68.
21. Venarske DL, Busse WW, Griffin MR et al. The relationship of rhinovirus-associated asthma hospitalizations with inhaled corticosteroids and smoking. J Infect Dis 2006 193 : 1536 43.
22. McCoy L, Redelings M, Sorvillo F, Simon P. A multiple cause-of-death analysis of asthma mortality in the United States, 1990-2001. J Asthma 2005 42 : 757 63.
23. Beuther DA, Weiss ST, Sutherland ER. Obesity and asthma. Am J Respir Crit Care Med 2006 174 : 112 9.
24. Miller MK, Lee JH, Miller DP, Wenzel SE. Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med 2007 101 : 481 9.
25. Vasudevan AR, Wu H, Xydakis AM et al. Eotaxin and obesity. J Clin Endocrinol Metab 2006 91 : 256 61.
26. Park SW, Kim DJ, Chang HS et al. Association of interleukin-5 and eotaxin with acute exacerbation of asthma. Int Arch Allergy Immunol 2003 131 : 283 90.
27. Shore SA. Obesity and asthma: possible mechanisms. J Allergy Clin Immunol 2008 121 : 1087 93 quiz 94-5.
28. Todd DC, Armstrong S, D'Silva L, Allen CJ, Hargreave FE, Parameswaran K. Effect of obesity on airway inflammation: a cross-sectional analysis of body mass index and sputum cell counts. Clin Exp Allergy 2007 37 : 1049 54.
29. Griswold SK, Nordstrom CR, Clark S, Gaeta TJ, Price ML, Camargo Jr. CA. Asthma exacerbations in North American adults: who are the "frequent fliers" in the emergency department? Chest 2005 127 : 1579 86.
30. Moore WC, Bleecker ER, Curran-Everett D et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 2007 119 : 405 13.
31. Koga T, Oshita Y, Kamimura T, Koga H, Aizawa H. Characterisation of patients with frequent exacerbation of asthma. Respir Med 2006 100 : 273 8.
32. ten Brinke A, Sterk PJ, Masclee AA et al. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J 2005 26 : 812 8.
33. Romagnoli M, Caramori G, Braccioni F et al. Near-fatal asthma phenotype in the ENFUMOSA Cohort. Clin Exp Allergy 2007 37 : 552 7.
34. Turner MO, Noertjojo K, Vedal S, Bai T, Crump S, Fitzgerald JM. Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma. Am J Respir Crit Care Med 1998 157 (Part 1) : 1804 9.
35. Boulet LP, Deschesnes F, Turcotte H, Gignac F. Near-fatal asthma: clinical and physiologic features, perception of bronchoconstriction, and psychologic profile. J Allergy Clin Immunol 1991 88 : 838 46.
36. Alvarez GG, Schulzer M, Jung D, Fitzgerald JM. A systematic review of risk factors associated with near-fatal and fatal asthma. Can Respir J 2005 12 : 265 70.
37. Black PN, Udy AA, Brodie SM. Sensitivity to fungal allergens is a risk factor for life-threatening asthma. Allergy 2000 55 : 501 4.
38. Peat JK, Woolcock AJ, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987 70 : 171 9.
39. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998 339 : 1194 200.
40. Aburuz S, McElnay J, Gamble J, Millership J, Heaney L. Relationship between lung function and asthma symptoms in patients with difficult to control asthma. J Asthma 2005 42 : 859 64.
41. Osborne ML, Pedula KL, O'Hollaren M et al. Assessing future need for acute care in adult asthmatics: the Profile of Asthma Risk Study: a prospective health maintenance organization-based study. Chest 2007 132 : 1151 61.
42. Bai TR, Vonk JM, Postma DS, Boezen HM. Severe exacerbations predict excess lung function decline in asthma. Eur Respir J 2007 30 : 452 6.
43. Oshita Y, Koga T, Kamimura T, Matsuo K, Rikimaru T, Aizawa H. Increased circulating 92 kDa matrix metalloproteinase (MMP-9) activity in exacerbations of asthma. Thorax 2003 58 : 757 60.
44. Holgate ST. Epithelium dysfunction in asthma. J Allergy Clin Immunol 2007 120 : 1233 44 quiz 45-6.
45. Hogg JC. The pathology of asthma. APMIS 1997 105 : 735 45.
46. Kuyper LM, Pare PD, Hogg JC et al. Characterization of airway plugging in fatal asthma. Am J Med 2003 115 : 6 11.
47. Lang DM, Simon RA, Mathison DA, Timms RM, Stevenson DD. Safety and possible efficacy of fiberoptic bronchoscopy with lavage in the management of refractory asthma with mucous impaction. Ann Allergy 1991 67 : 324 30.
48. Dunnill MS. The pathology of asthma, with special reference to changes in the bronchial mucosa. J Clin Pathol 1960 13 : 27 33.
49. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993 307 : 982 6.
50. Heymann PW, Carper HT, Murphy DD et al. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol 2004 114 : 239 47.
51. Wark PA, Johnston SL, Moric I, Simpson JL, Hensley MJ, Gibson PG. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 2002 19 : 68 75.
52. Grissell TV, Powell H, Shafren DR et al. Interleukin-10 gene expression in acute virus-induced asthma. Am J Respir Crit Care Med 2005 172 : 433 9.
53. Atmar RL, Guy E, Guntupalli KK et al. Respiratory tract viral infections in inner-city asthmatic adults. Arch Intern Med 1998 158 : 2453 9.
54. Johnston SL, Pattemore PK, Sanderson G et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995 310 : 1225 9.
55. Green RM, Custovic A, Sanderson G, Hunter J, Johnston SL, Woodcock A. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ 2002 324 : 763.
56. Lieberman D, Printz S, Ben-Yaakov M et al. Atypical pathogen infection in adults with acute exacerbation of bronchial asthma. Am J Respir Crit Care Med 2003 167 : 406 10.
57. Kistler A, Avila PC, Rouskin S et al. Pan-viral screening of respiratory tract infections in adults with and without asthma reveals unexpected human coronavirus and human rhinovirus diversity. J Infect Dis 2007 196 : 817 25.
58. Lemanske Jr. RF, Dick EC, Swenson CA, Vrtis RF, Busse WW. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest 1989 83 : 1 10.
59. Calhoun WJ, Swenson CA, Dick EC, Schwartz LB, Lemanske Jr. RF, Busse WW. Experimental rhinovirus 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis 1991 144 : 1267 73.
60. Calhoun WJ, Dick EC, Schwartz LB, Busse WW. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest 1994 94 : 2200 8.
61. Papadopoulos NG, Bates PJ, Bardin PG et al. Rhinoviruses infect the lower airways. J Infect Dis 2000 181 : 1875 84.
62. Chen Y, Hamati E, Lee PK et al. Rhinovirus induces airway epithelial gene expression through double-stranded RNA and IFN-dependent pathways. Am J Respir Cell Mol Biol 2006 34 : 192 203.
63. Spurrell JC, Wiehler S, Zaheer RS, Sanders SP, Proud D. Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 2005 289 : L85 95.
64. Corne JM, Holgate ST. Mechanisms of virus induced exacerbations of asthma. Thorax 1997 52 : 380 9.
65. Fahy JV, Kim KW, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995 95 : 843 52.
66. Ordonez CL, Shaughnessy TE, Matthay MA, Fahy JV. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: Clinical and biologic significance. Am J Respir Crit Care Med 2000 161 (Part 1) : 1185 90.
67. Lamblin C, Gosset P, Tillie-Leblond I et al. Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am J Respir Crit Care Med 1998 157 : 394 402.
68. Zhang N, Truong-Tran QA, Tancowny B, Harris KE, Schleimer RP. Glucocorticoids enhance or spare innate immunity: effects in airway epithelium are mediated by CCAAT/enhancer binding proteins. J Immunol 2007 179 : 578 89.
69. Greve JM, Davis G, Meyer AM et al. The major human rhinovirus receptor is ICAM-1. Cell 1989 56 : 839 47.
70. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001 413 : 732 8.
71. Takaoka A, Hayakawa S, Yanai H et al. Integration of interferon-alpha/ beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 2003 424 : 516 23.
72. Papadopoulos NG, Stanciu LA, Papi A, Holgate ST, Johnston SL. A defective type 1 response to rhinovirus in atopic asthma. Thorax 2002 57 : 328 32.
73. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem 1998 67 : 227 64.
74. Parry DE, Busse WW, Sukow KA, Dick CR, Swenson C, Gern JE. Rhinovirus-induced PBMC responses and outcome of experimental infection in allergic subjects. J Allergy Clin Immunol 2000 105 : 692 8.
75. Gern JE, Vrtis R, Grindle KA, Swenson C, Busse WW. Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med 2000 162 : 2226 31.
76. Silverman RA, Boudreaux ED, Woodruff PG, Clark S, Camargo Jr. CA. Cigarette smoking among asthmatic adults presenting to 64 emergency departments. Chest 2003 123 : 1472 9.
77. Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001 163 : 1304 9.
78. Innes AL, Woodruff PG, Ferrando RE et al. Epithelial mucin stores are increased in the large airways of smokers with airflow obstruction. Chest 2006 130 : 1102 8.
79. Ng TP, Lim TK, Abisheganaden J, Eng P, Sin FL. Factors associated with acute health care use in a national adult asthma management program. Ann Allergy Asthma Immunol 2006 97 : 784 93.
80. Eisner MD, Katz PP, Lactao G, Iribarren C. Impact of depressive symptoms on adult asthma outcomes. Ann Allergy Asthma Immunol 2005 94 : 566 74.
81. Wark PA, Johnston SL, Bucchieri F et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005 201 : 937 47.
82. Contoli M, Message SD, Laza-Stanca V et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 2006 12 : 1023 6.
83. Wenzel SE, Balzar S, Ampleford E et al. IL4R alpha mutations are associated with asthma exacerbations and mast cell/IgE expression. Am J Respir Crit Care Med 2007 175 : 570 6.
84. Sin DD, Man J, Sharpe H, Gan WQ, Man SF. Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis. JAMA 2004 292 : 367 76.
85. Salvi SS, Krishna MT, Sampson AP, Holgate ST. The anti-inflammatory effects of leukotriene-modifying drugs and their use in asthma. Chest 2001 119 : 1533 46.
86. Ringdal N, Eliraz A, Pruzinec R et al. The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma. Respir Med 2003 97 : 234 41.
87. Suzuki T, Yamaya M, Sekizawa K et al. Effects of dexamethasone on rhinovirus infection in cultured human tracheal epithelial cells. Am J Physiol Lung Cell Mol Physiol 2000 278 : L560 71.
88. Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999 159 (Part 1) : 1043 51.
89. Djukanovic R, Wilson SJ, Kraft M et al. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am J Respir Crit Care Med 2004 170 : 583 93.
90. Holgate ST. The role of mast cells and basophils in inflammation. Clin Exp Allergy 2000 30 (Suppl. 1) : 28 32.
91. Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH. Anti-IgE for chronic asthma in adults and children. Cochrane Database Syst Rev 2006 CD003559.
92. Brown R, Turk F, Dale P, Bousquet J. Response to Campbell, Spackman, Sullivan letter to Allergy. Allergy 2008 63 : 783.
93. Sullivan SD, Turk F. An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma. Allergy 2008 63 : 670 84.
94. Cheng JW, Arnold RJ. Pharmacoeconomic review of medical management of persistent asthma. Allergy Asthma Proc 2008 29 : 109 22.
95. Revicki D, Brown R, Dale P. Questioning the economic evaluation of omalizumab. J Allergy Clin Immunol 2008 121 : 1514 author reply -5.
96. Wu AC, Paltiel AD, Kuntz KM, Weiss ST, Fuhlbrigge AL. Cost-effectiveness of omalizumab in adults with severe asthma: results from the Asthma Policy Model. J Allergy Clin Immunol 2007 120 : 1146 52.
97. Krishnan JA, Gould M. Omalizumab for severe allergic asthma: dollars and sense. J Allergy Clin Immunol 2007 120 : 1015 7.
98. Belda J, Giner J, Casan P, Sanchis J. Mild exacerbations and eosinophilic inflammation in patients with stable, well-controlled asthma after 1 year of follow-up. Chest 2001 119 : 1011 7.
99. Green RH, Brightling CE, McKenna S et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002 360 : 1715 21.
100. Payne DN, Adcock IM, Wilson NM, Oates T, Scallan M, Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med 2001 164 (Part 1) : 1376 81.
101. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005 352 : 2163 73.
102. Fahy JV. Airway mucus and the mucociliary system. In : Middleton Jr. E, Reed CE, Ellis EF, Adkinson Jr. NF, Yunginger JW, Busse WW, eds. Allergy principles & practice, 5th Edn. St Louis : Mosby-Year Book Inc., 1998, pp. 520 31.